The National Medical Products Administration (NMPA) in China has issued market approval to Lanzhou Kejin Taiji Corporation, Ltd. for its carbon ion therapy system, marking it as the second home-grown carbon ion therapy system in the country designed for the treatment of malignant solid tumors.
Enhanced Features of the New Carbon Ion Therapy System
This cutting-edge product comprises four treatment rooms, with two additional rooms at 45-degree and 90-degree angles compared to previously approved domestic carbon ion products. These enhancements reduce the size of the modulation scanning treatment head beam spot, leading to improved precision. The system also boosts beam intensity and shortens beam cut-off time, which significantly improves treatment efficiency and safety.
Advanced Treatment Capabilities
The carbon ion therapy system is equipped with an image guidance system for precise targeting, and the patient support device has been upgraded for added comfort and stability during treatment. These improvements not only streamline the treatment process but also contribute to a higher success rate in treating malignant solid tumors.-Fineline Info & Tech
